세계의 멸균 서비스 시장 평가 : 방법별, 유형별, 전달 방식별, 최종 사용자별, 지역별 기회 예측(2017-2031년)

Global sterilization services market is projected to witness a CAGR of 5.77% during the forecast period 2024-2031, growing from USD 5.03 billion in 2023 to USD 7.87 billion in 2031. The market has undergone substantial growth and is expected to further grow manifold as we further advance in time due to which it can be a profitable market to invest in.

To contain the spread of infectious microorganisms and guarantee product safety, sterilization services refer to the methods and techniques used to remove or deactivate all types of microbial life, such as bacteria, viruses, fungi, and spores, from objects, surfaces, equipment, or environments. Maintaining sterility is crucial for product quality, regulatory compliance, and public health in several industries, including healthcare, pharmaceuticals, biotechnology, food and beverage, cosmetics, and manufacturing. Achieving total microbial elimination or inactivation while maintaining the integrity, usefulness, and efficacy of sterilized products is the main objective of sterilization services.

Market expansion is fueled by ongoing innovation and technological developments in sterilization supplies, tools, and processes. The need for sterilization services is being driven by advancements in sterilization technology, which include low temperature sterilization methods, rapid sterilization cycles, and alternative sterilization procedures. These technologies improve efficiency, shorten cycle times, and improve sterilization efficacy. The use of sterilization services in medical facilities, labs, and clinical settings is fueled by growing awareness of infection control practices, patient safety, and healthcare-associated infections (HAIs). To minimize the spread of pathogens, lower the risk of infection, and protect patient health and safety, sterilization is essential. The need for efficient sterilization procedures is highlighted by the rise of drug-resistant microbes, healthcare-associated infections (HAIs), and novel pathogens. To meet changing risks and guarantee sterilization techniques that are effective against newly developing infections and resistant strains, sterilization service providers must constantly innovate and adapt. For instance, with its ADVANTAGETM PLUS Pass-Through Automatic Endoscope Reprocessor (AER), Cantel Medical Corp., presently a subsidiary of STERIS plc., introduced high-level disinfection and increased efficiency of endoscope reprocessing in April 2023.

Emergence of New Pathogens and Drug-Resistant Microorganisms Leading to Market Expansion

The development of drug-resistant microbes and novel infections is largely fueling the market for sterilization services worldwide. Effective sterilization procedures are in greater demand as antibiotic-resistant germs and other infectious agents proliferate, endangering the safety of medications, medical equipment, and other goods. Advanced sterilization procedures are becoming more important for pharmaceutical firms, healthcare facilities, and laboratories to ensure compliance with strict regulatory standards and prevent the spread of illnesses. Sterilization measures must be strictly adhered to reduce the hazards associated with superbugs and the growth in healthcare-related infections (HAIs). As a result, sterilization services are now more widely used in a variety of industries, including biotechnology, healthcare, food and beverage, and pharmaceuticals. Further, various technological developments in sterilization techniques, such as ozone-based sterilization, vaporized hydrogen peroxide sterilization, and low-temperature sterilization, which offer more dependable and effective solutions are driving market expansion. Furthermore, the COVID-19 pandemic highlighted the need of sterilization in preserving public health, increasing demand for services capable of successfully removing viruses and other organisms from surfaces and equipment. Hence, the market for sterilization services is growing rapidly throughout the world due to the urgent need to address new health related risks and guarantee the security and effectiveness of goods and surroundings.

For instance, the multidrug-resistant fungus, Candida auris caused an outbreak in 2023, which brought attention to the urgent need for improved sterilization services. This bacterium quickly spread throughout healthcare facilities, posing a threat to the effectiveness of current infection control systems. It is known to cause severe infections with high fatality rates. As the Centers for Disease Control and Prevention (CDC) is stressing upon the need of strict sterilization procedures to stop its spread, more money has been invested in innovative sterilization technologies. This case demonstrates the critical role sterilization services play in controlling drug-resistant infections that are evolving and propelling market expansion in response to pressing public health concerns.

Growing Awareness About Infection Control and Patient Safety Fuel Market Growth

The global sterilization services market expansion is primarily driven by rising patient safety and infection control awareness. Healthcare-associated infections raise the risk of morbidity, death, and healthcare expenses while posing a major threat to patient safety. The need for efficient sterilization services has increased as healthcare facilities work to lower HAIs. To guarantee the highest levels of hygienic practices and sterilization in medical settings, governments and healthcare organizations across the globe are putting strict laws and rules into place. By taking these precautions, patients should be shielded against infections that could result from using surgical tools, medical equipment, or other equipment used in healthcare. In addition, strong sterilization procedures are now more important than ever to contain the spread of harmful infections such as multidrug-resistant organisms (MDROs). The market is expanding due to technological developments in sterilization procedures, including enhanced autoclaving technologies, vaporized hydrogen peroxide, and low temperature sterilization. Healthcare professionals who are committed to improving patient safety will find these advances intriguing since they provide safer, faster, and more effective sterilization choices. Moreover, the COVID-19 pandemic has highlighted the significance of strict infection control protocols, resulting in heightened funding for sterilization services. In the upcoming years, it is anticipated that the increased emphasis on upholding sterile conditions in healthcare facilities would support the market for sterilization services globally.

In 2023, the COVID-19 pandemic-induced increase in infection control measures that led to a notable surge in the global sterilization services industry. For instance, the European Centre for Disease Prevention and Control (ECDC) stated in January 2024 that hospital sterilization services increased 15% throughout Europe over the previous year. The necessity to uphold strict cleanliness standards to stop HAIs and the development of COVID-19, especially in surgical wards and intensive care units, was the main cause of this spike. This example shows how the market for sterilization services is growing as a direct result of recent events and greater regulatory scrutiny.

Hospitals and Clinics Segment to Dominate the Market Share

Factors including the high prevalence of chronic illness in the population and the rising number of surgical procedures led the hospitals and clinics segment of the sterilization services market to develop significantly over the forecast period. Furthermore, the proliferation of the coronavirus has raised awareness and demand for sterilization practices, which is further fostering market expansion. For instance, June 2022 data from the OECD indicates that around 93,857 cataract procedures were performed in Portugal in 2021, with 49,308 in Denmark and 32,844 in Ireland. Consequently, there is a greater need to properly sterilize surgical instruments, hospital rooms, and the surrounding area due to the large volume of procedures carried out in clinics and hospitals. Over the course of the projection year, the segment's expansion is expected to propel. As multispecialty hospitals and clinics proliferate throughout the world, sterilization is likely to become and more necessary. For instance, according to the OECD's 2022 data, Mexico reported 4,995 hospitals in 2021, compared to 4,909 in 2020. Furthermore, according to the same source, Austria had 268 hospitals in 2021 as opposed to 267 hospitals in 2020. The high rate of sterilization used by hospitals around the world is anticipated to support the segment's expansion during the projection period. In addition, it is expected that rising product launches and increased knowledge of sterilization techniques will support market expansion. Therefore, the segment is predicted to grow over the forecast period due to the causes, including the rising number of surgical procedures, expansion of hospitals, and the introduction of new products.

North America Dominates the Global Sterilization Services Market

North America's sophisticated healthcare system and strict regulations helped it become the leading region in the global sterilization services market in 2023. Modern hospitals, clinics, and research centers abound in the area, making comprehensive sterilization services essential to maintain the highest levels of patient care and security. Industries are required to follow stringent sterilization procedures by regulatory agencies such as the FDA in the United States. Since it is home to the world's top producers and suppliers of sterilization technology, North America is a center for technological innovation in sterilization techniques and apparatus. This encourages the use of cutting-edge methods and solutions in a variety of industries. A wide range of healthcare providers, such as hospitals, clinics, ambulatory surgical centres, and medical device makers, are included in the large North American healthcare market. Due to the region's enormous market size, there is a significant need for sterilization services in a variety of market areas, which further solidifies the region's supremacy in the global market. Due to strict regulatory requirements and technological improvements, North America has led the sterilization services market. The expansion of contract sterilization services offered by businesses such as Sterigenics U.S., LLC and Steris Corporation is one such example. For instance, to fulfil the rising demand for sterilization services across the food, pharmaceutical, and medical device industries, Sterigenics U.S., LLC dramatically expanded its operations in North America in 2022 by building new facilities and renovating those who already exist. Modern sterilization techniques such as ethylene oxide (EtO) and gamma irradiation, which are essential for guaranteeing the security and effectiveness of medical supplies, are now available from Sterigenics U.S., LLC due to this growth.

Future Market Scenario (2024 - 2031F)

Main factors contributing to the anticipated growth of sterilization services market are the rising awareness about patient safety and infection control, increasing prevalence of pathogens and microorganisms, and thus the rising requirement of sterilization services. However, the stringent regulations and rules to ensure certain sterilization processes is going to fuel the market growth in future. As the technology is advancing, innovation in the market is expected to rise. Players in the market are expanding at an un-paralleled rate, introducing cost-effective and efficient technologies. Policies made by welfare bodies and the governments across the world are greatly fueling the market expansion. For instance, to increase its presence in Europe, Sterigenics U.S., LLC announced in May 2023 that it acquired Beta-Gamma Service, a French provider of gamma irradiation sterilization services.

Key Players Landscape and Outlook

Several companies such are expanding businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed sterilization services to help researchers strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve a higher market share.

For instance, with the release of Reliance Fusion, an innovative sterilization wrap designed to maximize the sterilization process for surgical equipment trays within hospitals, Ahlstrom Oyj broadened its product line in the medical sector in May 2023. Reliance Fusion uses high-filtration Spunbond-Meltblown-Spunbond (SMS) construction together with wet-laid technology to combine the advantageous qualities of cellulose and polypropylene-based materials. This novel material allows for significant drying time reductions, reduces the possibility of wet packs, and increases sterilization efficiency for trays processed at Central Sterilization Service Departments (CSSD) in hospitals. This material's inclusion leads to savings on labor and energy expenses together with an improvement in throughput.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Sterilization Services Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Method
    • 4.2.1.1. Ethylene Oxide Sterilization
    • 4.2.1.2. Gamma Sterilization
    • 4.2.1.3. Electron-Beam Radiation Sterilization
    • 4.2.1.4. Steam Sterilization
    • 4.2.1.5. X-ray Irradiation
    • 4.2.1.6. Others
  • 4.2.2. By Type
    • 4.2.2.1. Contract Sterilization Services
    • 4.2.2.2. Sterilization Validation Services
  • 4.2.3. By Mode of Delivery
    • 4.2.3.1.1. Off-site Sterilization Services
    • 4.2.3.1.2. On-site Sterilization Services
  • 4.2.4. By End-user
    • 4.2.4.1. Medical Device Companies
    • 4.2.4.2. Hospitals and Clinics
    • 4.2.4.3. Pharmaceuticals and Biotechnology Companies
    • 4.2.4.4. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia-Pacific
    • 4.2.5.4. South America
    • 4.2.5.5. Middle East and Africa
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Method
  • 4.3.2. By Type
  • 4.3.3. By Mode of Delivery
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. North America Sterilization Services Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Method
    • 5.2.1.1. Ethylene Oxide Sterilization
    • 5.2.1.2. Gamma Sterilization
    • 5.2.1.3. Electron-Beam Radiation Sterilization
    • 5.2.1.4. Steam Sterilization
    • 5.2.1.5. X-ray Irradiation
    • 5.2.1.6. Others
  • 5.2.2. By Type
    • 5.2.2.1. Contract Sterilization Services
    • 5.2.2.2. Sterilization Validation Services
  • 5.2.3. By Mode of Delivery
    • 5.2.3.1.1. Off-site Sterilization Services
    • 5.2.3.1.2. On-site Sterilization Services
  • 5.2.4. By End-user
    • 5.2.4.1. Medical Device Companies
    • 5.2.4.2. Hospitals and Clinics
    • 5.2.4.3. Pharmaceuticals and Biotechnology Companies
    • 5.2.4.4. Others
  • 5.2.5. By Country Share
    • 5.2.5.1. United States
    • 5.2.5.2. Canada
    • 5.2.5.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Sterilization Services Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Method
        • 5.3.1.2.1.1. Ethylene Oxide Sterilization
        • 5.3.1.2.1.2. Gamma Sterilization
        • 5.3.1.2.1.3. Electron-Beam Radiation Sterilization
        • 5.3.1.2.1.4. Steam Sterilization
        • 5.3.1.2.1.5. X-ray Irradiation
        • 5.3.1.2.1.6. Others
      • 5.3.1.2.2. By Type
        • 5.3.1.2.2.1. Contract Sterilization Services
        • 5.3.1.2.2.2. Sterilization Validation Services
      • 5.3.1.2.3. By Mode of Delivery
        • 5.3.1.2.3.1. Off-site Sterilization Services
        • 5.3.1.2.3.2. On-site Sterilization Services
      • 5.3.1.2.4. By End-user
        • 5.3.1.2.4.1. Medical Device Companies
        • 5.3.1.2.4.2. Hospitals and Clinics
        • 5.3.1.2.4.3. Pharmaceuticals and Biotechnology Companies
        • 5.3.1.2.4.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Sterilization Services Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Sterilization Services Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Sterilization Services Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Sterilization Services Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. STERIS plc
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 21.3.2. Sterigenics U.S., LLC
  • 21.3.3. Stryker Corporation
  • 21.3.4. E-BEAM Services, Inc.
  • 21.3.5. MMM Group
  • 21.3.6. Belimed AG
  • 21.3.7. Noxilizer, Inc.
  • 21.3.8. Cosmed Group
  • 21.3.9. Medline Industries, Inc.
  • 21.3.10. Avantti Medi Clear

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer